Cagrilintide / GLP-1
A careful way to separate interest in a molecule from evidence, approval, and product claims.
At a glance
- Evidence stage
- Preclinical
- Regulatory status
- Cagrilintide / GLP-1 is not FDA-approved for any use; research material sold under this name is not a regulated drug product.
- Research context
- Cagrilintide / GLP-1 is studied mainly in laboratory and animal (preclinical) metabolic health research; mechanism and animal findings do not establish human safety or benefit.
What this is
- Cagrilintide / GLP-1 is discussed here as a subject of laboratory and animal (preclinical) research.
- Published findings focus on mechanism and early biology, not proven outcomes in people.
- Cagrilintide / GLP-1 is not an FDA-approved drug for any consumer, clinical, or performance use.
What this isn't
- This page is not medical advice or a treatment recommendation involving Cagrilintide / GLP-1.
- This is not a dosing guide — no dose, schedule, or administration instructions are implied.
- This is not proof that Cagrilintide / GLP-1 is safe or effective for use in humans.
Key terms
Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Cagrilintide may be discussed alongside metabolic-health research. FDA states that it is not a component of an FDA-approved drug, has not been found safe and effective for any condition, and cannot be used in compounding under federal law. Review the current FDA information rather than relying on social-media claims or ingredient names alone.
Evidence limits
How to read the evidence
Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
When reading research, distinguish a study intervention from a product offered outside that study. Check the comparator, participant population, duration, prespecified outcomes, adverse-event reporting, and whether results are independently replicated.
Coverage
In the news
Recent reporting about this molecule. Headlines are not clinical guidance.
- In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides - STATSTAT · 2026-07-23 · External ↗
- What to Know About Peptides the FDA Is Considering for Use - The New York TimesThe New York Times · 2026-07-23 · External ↗
- FDA advisers recommend relaxing US rules on compounding peptides - ReutersReuters · 2026-07-24 · External ↗
External sources and citations
- FDA safety information on unapproved GLP-1 products
- Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. The New England journal of medicine, 2025
- Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes. The New England journal of medicine, 2025
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet (London, England), 2021
- Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet (London, England), 2023
- Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity. Cardiology in review, 2024
- Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis. Indian journal of endocrinology and metabolism, 2024
- Development of Cagrilintide, a Long-Acting Amylin Analogue. Journal of medicinal chemistry, 2021
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet (London, England), 2021
Common questions
What is Cagrilintide / GLP-1?
Cagrilintide / GLP-1 is discussed in research and educational contexts as a named molecule or product label. Identity, purity, and studied form can differ across sources — a name match alone is not proof of the same material used in a study.
What does the evidence for Cagrilintide / GLP-1 actually show?
Evidence for Cagrilintide / GLP-1 ranges by question: preclinical models, early human work, or approved uses for specific indications. Mechanism findings and animal data do not automatically predict clinical benefit or safety in people.
Is Cagrilintide / GLP-1 FDA-approved for general use?
Do not assume Cagrilintide / GLP-1 is FDA-approved for the use you have in mind. Approvals are indication-specific. Many research peptides and compounded products are not approved drugs for consumer or athletic use.
What product-quality questions should I ask about Cagrilintide / GLP-1?
Ask what was tested (identity, purity, potency), who tested it, and whether the label matches the studied form. Third-party certificates, storage conditions, and supplier transparency matter more than marketing claims.
How is Cagrilintide / GLP-1 different from similarly named products?
Blends, salts, fragments, and brand nicknames are often confused with Cagrilintide / GLP-1. Verify the exact molecule, dose unit, and route in any citation before treating it as evidence for a different product.
Related peptides
Other published briefs in the same research family. Educational references only - not treatment recommendations.
5-Amino-1MQ
When a laboratory value changes but patient outcomes remain uncertain.
Open resourcePeptide brief5-Amino-1MQ / SLU-PP-332
Why the same acronym can refer to different molecules, salts, fragments, or blends.
Open resourcePeptide briefAOD-9604
A framework for evaluating evidence and regulatory claims around an hGH-fragment research compound.
Open resourcePeptide briefATX-304
A practical guide to research stage, controls, endpoints, uncertainty, and applicability.
Open resourcePeptide briefBAM15
Why a compelling cell or animal result is the beginning of a question, not the end of it.
Open resourcePeptide briefCagrilintide
A careful way to separate interest in a molecule from evidence, approval, and product claims.
Open resourceLearn the research basics
Foundational literacy pieces that help interpret evidence stage, product identity, and study design.
How to read a peptide study without overclaiming
A practical guide to research stage, controls, endpoints, uncertainty, and applicability.
Open resourceLiteracyWhy a biological mechanism is not a treatment promise
A practical explanation of why plausible pathways still need meaningful human-outcome evidence.
Open resourceLiteracyPeptide naming, aliases, and product identity
Why the same acronym can refer to different molecules, salts, fragments, or blends.
Open resourceLiteracyFrom preclinical finding to human evidence
Why a compelling cell or animal result is the beginning of a question, not the end of it.
Open resourceLiteracyFDA approved, compounded, and unapproved are not synonyms
A plain-language map of product categories that are often blurred in peptide discussions.
Open resourceLiteracyUnderstanding surrogate endpoints in peptide research
When a laboratory value changes but patient outcomes remain uncertain.
Open resourceWatch & read
Same-family videos and articles from the Articles & Media channel. Educational references only.
The Best Peptide for Insulin Resistance & Mitochondrial Health: MOTS-C Masterclass
Dr. Venn-Watson's new book, The Longevity Nutrient: The Unexpected Fat That Holds the Key to Healthy Aging: https://a.co/d/6nIdp0E Use Code THOMAS for 15% off Fatty15: http://fatty15.com/thomas This video does contain a paid partnership with a brand that helps to support this channel. It is because of brands like this that we are able to provide the content that we do for free. Click HERE to Subscribe: https://www.youtube.com/c/ThomasDeLauerOfficial?sub_confirmation=1 Please check out the new Shorts channel, DeLauer Clips and Workouts, here: https://www.youtube.com/channel/UCQPQImPsw74KhO0Zy2-leyA/videos Please Subscribe to my Email Newsletter Here: https://www.thomasdelauer.com/life-optimization-tactics/ Follow More of My Daily Life on Instagram: http://www.Instagram.com/ThomasDeLauer References https://www.nature.com/articles/s41467-020-20790-0 https://www.cell.com/cell-metabolism/fulltext/S1550-4131(15)00061-3 https://www.nature.com/articles/s41467-020-20790-0 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238132/ http://oinmarketcap.com/rankings/exchanges/dex/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138593/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693465/ https://www.nature.com/articles/s41467-020-20790-0 Timestamps ⏱ 0:00 - Intro 1:17 - Fatty15 2:28 - MOTS-C Exercise Benefits 5:08 - Effects on Insulin Resistance & Inflammation 6:02 - How is This Happening? 6:55 - MOTS-C to Improve Exercise Performance 8:55 - Muscle Building Benefits 10:42 - Effect on Longevity
Open resourceVideoTesamorelin: The Peptide for Fat Loss, Muscle Preservation, and Metabolic Health
Tesamorelin is a powerful growth hormone-releasing peptide known for its ability to support fat loss, muscle preservation, and metabolic health. Originally developed for medical use, it has gained attention in functional and regenerative medicine for its potential benefits in reducing visceral fat, improving body composition, and enhancing overall metabolic function. In this video, I break down: How Tesamorelin Works Its Role in Fat Loss and Muscle Retention Potential Benefits for Metabolic Health and Longevity Who Might Benefit from Tesamorelin Therapy If you're interested in learning more about how peptides like Tesamorelin can optimize health and performance, visit our website: 🔗 https://www.apex-healthwellness.com/ Medical Disclaimer: This video is for informational and educational purposes only and is not intended as medical advice. Tesamorelin is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Always consult with a licensed medical provider before beginning any new treatment or therapy. Compensation Disclosure: Some of the links provided in this description may lead to third-party platforms where I receive a commission or other financial benefit. This disclosure is made in accordance with applicable regulations concerning transparency and material financial relationships.
Open resourceVideo90: Peptides & Metabolism - Fat Loss, Muscle Growth, and Hormones Explained with Dr. Bikman
📢 Ask Dr. Bikman’s Digital Mind: https://benbikman.com/ben-bikmans-digital-ai-mind Dr. Bikman’s Metabolic Classroom lecture this week explores peptides and their effects on metabolism, fat loss, muscle growth, and overall health. Ben begins by defining peptides as short chains of amino acids that act as signaling molecules in the body. While some peptides occur naturally, others are synthetically developed for therapeutic purposes. He explains that peptides are gaining popularity in fitness, anti-aging, and metabolic health, influencing fat loss, muscle repair, insulin sensitivity, and even skin regeneration. He also introduces collagen peptides, highlighting their unexpected metabolic benefits, including their influence on GLP-1 and gut microbiome health. Ben then categorizes peptides based on their primary functions. For fat loss, peptides like CJC-1295 and Tesamorelin work by stimulating growth hormone and IGF-1, promoting fat breakdown while preserving muscle mass. Another peptide, Melanotan-2, originally known for increasing melanin, has been found to suppress appetite by affecting the melanocortin system. He also discusses peptides like Ipamorelin, which help enhance muscle recovery and growth by selectively increasing growth hormone secretion without affecting other pituitary hormones. In the anti-aging and skin health category, Thymosin Beta-4 stands out for its ability to enhance wound healing and tissue repair. Dr. Bikman also highlights the unexpected metabolic role of collagen peptides, explaining how they can increase GLP-1 levels, improve insulin sensitivity, and even activate AMPK, a crucial metabolic regulator involved in fat breakdown and cellular repair. Finally, he touches on how peptides are administered—most commonly via subcutaneous injections, though some peptides can be absorbed sublingually or applied topically. He cautions that not all peptides are created equal, warning against low-quality or counterfeit products. Ben emphasizes the
Open resourceVideoMOTS-C: Mitochondrial Peptide for Metabolic Reset, Muscle Preservation & Longevity Upgrade
MOTS-C FAQ — Science, Dosing, Safety, Results What is MOTS-C? MOTS-C is a mitochondrial-derived peptide discovered at USC/Harvard. It improves how your cells use fuel by activating AMPK, increasing glucose uptake, and enhancing mitochondrial stress-resilience. ⸻ Does MOTS-C burn fat? Indirectly, yes — by improving metabolic flexibility: • better insulin sensitivity • increased fat oxidation during exercise • improved muscle glucose handling But it is not a GLP-1 and doesn’t suppress appetite. ⸻ What benefits can you realistically expect? Human and animal studies show improvements in: • insulin sensitivity • energy + exercise capacity • recovery and mitochondrial function • inflammation and metabolic markers • muscle performance, especially in older adults In practice, many report: • cleaner energy • better workouts • easier glucose control • less post-exercise soreness ⸻ What is the optimal dosing? Clinically, most people use: 5–10 mg, 2–3× per week or every 5 days, depending on training load. MOTS-C works best when pulsed, not daily — mitochondrial peptides respond to spikes, not constant exposure. ⸻ Can you combine MOTS-C with Semaglutide / GLP-1 agonists? Yes. They work on complementary pathways: • GLP-1 → appetite + glucose regulation • MOTS-C → mitochondrial efficiency + exercise capacity This combination often helps prevent muscle loss during weight-cutting phases (if protein and strength training are adequate). ⸻ Does age matter? Older adults often respond extremely well because MOTS-C restores mitochondrial pathways that decline with age. ⸻ How fast do you feel results? Some feel better energy in 3–5 days. Exercise performance and metabolic markers improve over 3–6 weeks. ⸻ Is MOTS-C safe? Current research shows: ✔ good safety profile ✔ no known organ toxicity ✔ naturally occurring in the body But clinical use should still be guided by a physician. ⸻ Can MOTS-C help with muscle, strength, or recovery? Yes — MOTS-C improves AMPK s
Open resourceArticleAn ingredient name is not a complete product
Why matching a molecule name does not establish sameness in approval, formulation, quality, or evidence.
Open resourceArticleCompounded is not the same as generic
A plain-language explanation of two categories that are often incorrectly treated as interchangeable.
Open resourceRelated articles
Same-family articles from the published library. Educational references only - not treatment recommendations.
An ingredient name is not a complete product
Why matching a molecule name does not establish sameness in approval, formulation, quality, or evidence.
Open resourceArticleCompounded is not the same as generic
A plain-language explanation of two categories that are often incorrectly treated as interchangeable.
Open resource